FDA Clears Novo Nordisk’s Needle-Free Wegovy Pill for January 2026 Launch

Bagsværd, Tuesday, 23 December 2025.
Novo Nordisk secures a market first with FDA approval for oral Wegovy. Launching January 2026, this needle-free option demonstrated 16.6% weight loss, challenging the dominance of injectables.